Updated Pick,Peptides that are stable at neutral pH and 37 °C

The pH stability of peptides is a paramount concern in various scientific and therapeutic fields. Understanding how pH influences peptide structure and function is crucial for their successful development and application, particularly in drug discovery and delivery. This article delves into the multifaceted aspects of peptide stability under different pH conditions, exploring the underlying mechanisms and outlining strategies to enhance their resilience.

Peptides are short chains of amino acids, and their overall charge, conformation, and consequently, their stability, are highly sensitive to the surrounding pH. Changes in pH can alter the ionization state of amino acid residues within the peptide chain, leading to modifications in intra- and intermolecular interactions. For instance, at low pH, acidic residues (like aspartic acid and glutamic acid) become protonated, while basic residues (like lysine and arginine) remain protonated. Conversely, at high pH, acidic residues are deprotonated, and basic residues may become deprotonated. These charge variations directly impact electrostatic interactions, which are fundamental to maintaining a peptide's three-dimensional structure. Research has shown that due to pH changes, the charges of peptides change accordingly, leading to different electrostatic interactions.

One of the primary concerns for peptide therapeutics is their viability in physiological environments. Peptides that are stable at neutral pH (around 7.4) and body temperature (37 °C) for a reasonable period are more viable as therapeutics. However, the human body presents a range of pH environments, from the highly acidic stomach (around pH 1.5-3.5) to the neutral small intestine and the slightly alkaline blood. Therefore, peptide stability across this spectrum is critical. For example, some peptides are designed to be stable at a specific pH to exert their function. pHLIPs (pH-Low Insertion Peptides) are a notable example of pH-sensitive peptides that exploit pH differences between healthy and diseased cells. These pH-sensitive, moderately polar membrane peptides are designed to insert into cellular membranes, with their activity triggered by acidic pH. Similarly, peptides can be cyclized to increase their stability at the low pH in the stomach, while they linearize at neutral pH to form the active peptide.

The impact of pH on peptide stability can manifest in various degradation pathways. Hydrolysis of the peptide backbone, deamidation of asparagine and glutamine residues, and oxidation of susceptible amino acids (like methionine and cysteine) are common degradation routes influenced by pH. For instance, Exenatide remained relatively stable at pH 4.5 when incubated at 37 °C. At pH 5.5–6.5, degradation was driven by oxidation, while driven by deamidation at pH 7. This highlights that each peptide has an optimal pH range for stability, and deviating from this range can accelerate degradation.

Beyond physiological conditions, pH also plays a significant role in peptide formulation, purification, and storage. During purification processes, modulating the pH of the mobile phase can effectively separate peptides from their contaminants. The solubility guidelines for peptides often include recommendations based on pH and buffer selection. For storage, lyophilized formats are frequently recommended, typically at –20 °C or –80 °C, to minimize degradation. However, even during lyophilization, pH can be a factor. Phosphate buffers, for example, can undergo selective crystallization during freezing, shifting pH by up to 3.5 units. Therefore, selecting appropriate buffer systems, such as histidine, Tris, or citrate buffers, is crucial to maintain the desired pH and ensure peptide stability. pH is crucial for peptide stability, and selecting an appropriate buffer helps minimize degradation in aqueous solutions.

Strategies to improve peptide stability often involve chemical modifications or formulation approaches. One effective method is peptide cyclization, which can rigidify the peptide structure and protect it from enzymatic degradation and other destabilizing factors. The combination of peptide and excipients can also influence stability. Sugars like trehalose and mannitol can act as cryoprotectants and stabilizers during lyophilization, while antioxidants can mitigate oxidative degradation.

Furthermore, understanding the pH-induced changes in polypeptide conformation is vital. For example, in a narrow pH range, both pH 9.8–10.4 for PLL and pH 5.0–5.5 for PGA, polypeptides remain sufficiently charged. Research into pH-responsive self-assembling peptide-based biomaterial designs and applications is an active area, leveraging the reversible nature of peptide assembly controlled by pH changes.

In conclusion, the pH stability of peptides is a multifaceted issue with profound implications for their therapeutic potential. From formulation and storage to in vivo performance, understanding and controlling pH is essential. Researchers are continuously exploring new optimization strategies to enhance peptide stability and bioavailability for therapeutic applications, ensuring